Eloxx Pharmaceuticals, Inc. (ELOX) [Rocket]

News + Filings

All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Consulting agrmnt
Inv. presentation

Eloxx Pharmaceuticals, Inc. (ELOX)

Create: Alert

All | News | Filings

Date Filed	Type	Description
04/29/2021	GN	Eloxx Pharmaceuticals Adds Additional Treatment Arm to Ongoing Phase 2 Clinical Studies for Cystic Fibrosis
04/01/2021	GN	Eloxx Pharmaceuticals Acquires Zikani Therapeutics
03/04/2021	GN	Eloxx Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Business Update on March 11, 2021
01/26/2021	GN	Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Clinical Pharmacology in Drug Development
01/20/2021	GN	Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Clinical Pharmacology
01/13/2021	GN	Eloxx Pharmaceuticals Announces Cystic Fibrosis Foundation (CF Foundation) To Provide Increased Funding and Support for ELX-02 Global Phase 2 Clinical Trial Program
11/18/2020	GN	Eloxx Pharmaceuticals to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
10/27/2020	GN	Eloxx Announces The Publication of Two Manuscripts on ELX-02 and It's ERSG Library In Two Leading Journals
10/22/2020	GN	Eloxx Presents Two Preclinical Posters at the 2020 North American Cystic Fibrosis Virtual Conference
10/15/2020	GN	Eloxx Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Business Update on November 5, 2020
09/14/2020	GN	Globally Renowned Cystic Fibrosis Expert, Dr. Eitan Kerem, Joins Eloxx Pharmaceuticals as a Senior Consultant
08/26/2020	GN	Eloxx Announces Two Preclinical Abstracts Accepted for Presentation at the 2020 North American Cystic Fibrosis Virtual Conference in October

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy